Rich leads EY’s West Region Life Sciences practice, is EY’s US Biotech leader, and leads our US and Global Life Sciences Assurance practice. He is an audit partner with over 30 years of experience serving life sciences companies ranging from large, multinational corporations to privately-held startups. He brings a collaborative approach that blends deep industry knowledge with a practical application of the often-complex rules and regulations that clients deal with on a daily basis. As part of his various leadership roles Rich sits on EY’s US and Global Life Sciences Boards, which are responsible for understanding market trends and how they impact the EY life sciences practice, prioritizing the allocation of resources, and assessing and advising on acquisitions and investment opportunities. Rich is also responsible for the coordination and execution of audit, tax, and consulting services across our US biotech practice, including overseeing the more than 30 IPO's completed by the practice in the last several years.. As West Region Life Sciences Leader, Rich has responsibility for the market and related activities of the partners and staff that serve the over 100 public and 250 private life science clients in the EY West region.